153 related articles for article (PubMed ID: 31862196)
1. Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
Bertran K; Criado MF; Lee DH; Killmaster L; Sá E Silva M; Lucio E; Widener J; Pritchard N; Atkins E; Mebatsion T; Swayne DE
Vaccine; 2020 Feb; 38(6):1526-1534. PubMed ID: 31862196
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
Criado MF; Bertran K; Lee DH; Killmaster L; Stephens CB; Spackman E; Sa E Silva M; Atkins E; Mebatsion T; Widener J; Pritchard N; King H; Swayne DE
Vaccine; 2019 Apr; 37(16):2232-2243. PubMed ID: 30885512
[TBL] [Abstract][Full Text] [Related]
3. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
5. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus.
Hussein HA; Ahmed BM; Aly SM; El-Deeb AH; El-Sanousi AA; Rohaim MA; Arafa AA; Gadalla MR
Acta Virol; 2016; 60(3):307-15. PubMed ID: 27640441
[TBL] [Abstract][Full Text] [Related]
7. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
Bertran K; Balzli C; Lee DH; Suarez DL; Kapczynski DR; Swayne DE
Vaccine; 2017 Nov; 35(46):6336-6344. PubMed ID: 28554502
[TBL] [Abstract][Full Text] [Related]
8. Development and use of fowlpox vectored vaccines for avian influenza.
Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
Kapczynski DR; Chrzastek K; Shanmugasundaram R; Zsak A; Segovia K; Sellers H; Suarez DL
Virol J; 2023 Dec; 20(1):298. PubMed ID: 38102683
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
[TBL] [Abstract][Full Text] [Related]
11. Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.
Eggert D; Thomas C; Spackman E; Pritchard N; Rojo F; Bublot M; Swayne DE
Vaccine; 2010 Jun; 28(29):4609-15. PubMed ID: 20470798
[TBL] [Abstract][Full Text] [Related]
12. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
Balzli CL; Bertran K; Lee DH; Killmaster L; Pritchard N; Linz P; Mebatsion T; Swayne DE
Vaccine; 2018 Jan; 36(1):84-90. PubMed ID: 29180030
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
Swayne DE; Beck JR; Mickle TR
Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
Bertran K; Kassa A; Criado MF; Nuñez IA; Lee DH; Killmaster L; Sá E Silva M; Ross TM; Mebatsion T; Pritchard N; Swayne DE
Vaccine; 2021 Apr; 39(14):1933-1942. PubMed ID: 33715903
[TBL] [Abstract][Full Text] [Related]
16. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.
Swayne DE; Garcia M; Beck JR; Kinney N; Suarez DL
Vaccine; 2000 Jan; 18(11-12):1088-95. PubMed ID: 10590330
[TBL] [Abstract][Full Text] [Related]
17. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
18. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
[TBL] [Abstract][Full Text] [Related]
19. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
20. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE
Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
